about
Influence of socio-economic and lifestyle factors on overweight and nutrition-related diseases among Tunisian migrants versus non-migrant Tunisians and FrenchBlood pressure and associated factors in a North African adolescent population. a national cross-sectional study in Tunisia.Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal.Gender obesity inequities are huge but differ greatly according to environment and socio-economics in a North African setting: a national cross-sectional study in TunisiaNutrition transition among adolescents of a south-Mediterranean country: dietary patterns, association with socio-economic factors, overweight and blood pressure. A cross-sectional study in Tunisia.Obesity and association with area of residence, gender and socio-economic factors in Algerian and Tunisian adults.Abdominal vs. overall obesity among women in a nutrition transition context: geographic and socio-economic patterns of abdominal-only obesity in Tunisia.Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in AfricaVirological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon.Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in CameroonSingle real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains.Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated FactorsField evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, oExtraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.Nutritional status of Tunisian adolescents: associated gender, environmental and socio-economic factors.Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers.Influence of acculturation among Tunisian migrants in France and their past/present exposure to the home country on diet and physical activity.Diet quality of North African migrants in France partly explains their lower prevalence of diet-related chronic conditions relative to their native French peers.Evolution of renal function in African patients initiating second-line antiretroviral treatment: findings from the ANRS 12169 2LADY trial.Food shopping transition: socio-economic characteristics and motivations associated with use of supermarkets in a North African urban environment.Regular users of supermarkets in Greater Tunis have a slightly improved diet quality.Chest Low-Dose Computed Tomography for Early Lung Cancer Diagnosis as an Opportunity to Diagnose Vertebral Fractures in HIV-Infected Smokers, an ANRS EP48 HIV CHEST Substudy.Knowledge of dietary and behaviour-related determinants of non-communicable disease in urban Senegalese women.Assessment of child feeding practices using a summary index: stability over time and association with child growth in urban Madagascar.Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon.Field evaluation of an open and polyvalent universal HIV-1/SIVcpz/SIVgor quantitative RT-PCR assay for HIV-1 viral load monitoring in comparison to Abbott RealTime HIV-1 in Cameroon.Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa.Monoclonal Gammopathy in HIV-1-Infected Patients: Factors Associated With Disappearance Under Long-Term Antiretroviral Therapy.Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial.Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring.TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study.Dietary diversity scores and nutritional status of women change during the seasonal food shortage in rural Burkina Faso.Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort study.Challenges of antiretroviral treatment monitoring in rural and remote-access regions in Africa.HIV is associated with airway obstruction: a matched controlled study.Comparison of different nucleic acid preparation methods to improve specific HIV-1 RNA isolation for viral load testing on dried blood spots.High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers.Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir.
P50
Q33300284-172F2F4D-7A8F-4858-96B6-625F65CA58C2Q34150574-58C54A54-4137-4097-84DE-ED0B8561AD7CQ34168353-7E3396B1-05E8-41BF-8300-5FE8E55AA2C7Q34464816-CE78C755-25D7-4ABF-B77B-C14B1DB21A71Q34994958-F3E45EF6-0257-4AC8-B269-FD1313D97AE6Q35014511-A48C2D9F-9232-482D-93FA-657E9AAA649DQ35151388-21C7703F-F9CF-4C41-A582-64423DC50543Q35853812-99208462-089C-443D-B6AE-AC48DE364010Q36435445-DC3F6E06-D05B-47F4-A97B-FA45ADFA6675Q36581795-4A1E0B63-1140-493E-B58F-BDEB6BD630D3Q36667567-3F871A98-7B1A-4E31-B70F-6CD30D065FF9Q37156843-CEA9DEB2-2A70-49BD-8ACF-4FA372D599BBQ37546113-BB62A0C8-71F3-4962-A231-4A71AD523729Q38752758-E3939392-FF43-445E-9C2E-85233C4CCF43Q38862291-65862D84-F2D4-47D3-91AE-9AC5FBAE5BECQ38877506-4FEBF703-41DC-42FE-9BC8-CC90179562CBQ39196660-E279EB98-2B79-4B58-A372-DFA1AA812E44Q39206781-2CC2E155-D56F-475E-AEA0-F39BD0FD624FQ39286887-CC8FE9CF-FF54-4728-84EC-D1BBE60AE3E2Q39286897-0B2B9CAA-0835-47E1-8C99-5949FAF4273FQ39321013-74C5E663-612A-4426-9637-F17B4CFE9BA2Q39518523-3A9692AC-72BB-41AC-8058-74CD75EB62D6Q39518531-D08F225B-6BD7-443C-BFD6-881BB445F463Q39523245-71984070-9058-40B7-A696-0B6F7398C4BAQ39776222-F20A3DA3-AC8C-4DB2-BAF4-F10882D486C7Q39845886-664E0A7F-7BBD-43F8-BF0A-B5F6E85E6851Q40486177-BCD365FB-FC43-4523-9406-473A4E2199D9Q40546379-5C72D7D8-4982-4FE9-AECE-02FE33383727Q40683022-7150E702-2B0B-44B5-A941-0EA1EE7CB30FQ41187521-2B23093A-A478-4A07-833B-590BE6147842Q42250176-2D37BE43-5AA3-4623-8AE1-212D593FFD1EQ42966049-CA3F3C3D-30A9-4869-A8DD-902D4E92C50BQ43923848-81D4514F-F773-4190-9F35-49265C9C8746Q43933025-9A02EAFF-F496-412F-80E1-7D501B3B9EAAQ45181648-5208AFFD-1707-42E1-A421-9C80B3E8FBF9Q46966473-04A586E0-7BD1-4F87-82AB-D7FD76639D91Q47580927-DBC5A57D-138C-4B0F-8F85-F83127F4E88BQ47610604-0C601CD8-88F8-4CBC-BE69-2899E20F3F2DQ51690180-0F15181A-6BB2-4EF6-8B02-2F8839E1B7C2Q52633128-1C7B7AFF-8472-44E8-A182-16E894944294
P50
name
Sabrina Eymard-Duvernay
@ast
Sabrina Eymard-Duvernay
@en
Sabrina Eymard-Duvernay
@es
Sabrina Eymard-Duvernay
@nl
type
label
Sabrina Eymard-Duvernay
@ast
Sabrina Eymard-Duvernay
@en
Sabrina Eymard-Duvernay
@es
Sabrina Eymard-Duvernay
@nl
prefLabel
Sabrina Eymard-Duvernay
@ast
Sabrina Eymard-Duvernay
@en
Sabrina Eymard-Duvernay
@es
Sabrina Eymard-Duvernay
@nl